Save Alvin From Cancer & Many More
In our quest to save his life, we read about a new version of a genetic medicine that has cured patients with bone cancer and pancreatic cancer. We are optimistic that if Alvin can be treated with this medicine, he has a chance of winning his battle against cancer.
The challenge we face is the high cost of drug manufacturing. Through gofundme.com, we are raising the $350,000 needed to make the drug. If this treatment works for Alvin, it will open the door to other cancer patients who could benefit from this treatment as well! We pray that you will help us raise the funds needed. This is an urgent matter; the sooner we get the funding, the sooner we can start Alvin's cure! Please help us SAVE ALVIN FROM CANCER and in so doing, SAVE OTHER CANCER VICTIMS!
I am posting a prayer card with the biography of Fr. Joseph Aveni, a 92-year old Italian Rogationist priest who recovered from terminal cancer upon receiving a version of AVE-012 gene therapy. He was dying of kidney failure and bone cancer. According to his doctors, he was too weak to receive chemotherapy and had less than one month to live. He was bedridden with severe bone pain. The Father Superior of the Rogationist seminary requested the gene therapy for compassionate reasons, only to help reduce his pain. After three treatments, Father Aveni's pain subsided and his kidneys started working again. Two months later, he was able to walk. When his health continued to improve, he said Holy Mass, taught the Rogationist seminarians, and comforted the cancer patients who came to the clinic for his blessing. Father Aveni completed the gene therapy over the next year without any side effects. Five years after his passing from natural causes, the process of Father Aveni's canonization has begun
AVE-012 is believed to be the next generation targeted genetic medicine for cancer. When injected into a vein, billions of AVE-012 nanoparticles flow through the blood circulation, and within seconds, seek out and accumulate in cancerous areas, and deliver two lethal genes to the cancer cells without damaging normal organs or the immune system. The dual strategy of AVE-012 would make it more effective at eradicating the cancer with minimal side effects. A previous version of this new gene therapy was used to treat a priest from Rome who overcame his cancer that had spread to the kidneys and bones.
Thanks to your generous donations, we are now a step closer towards making AVE-012. The AVE-012 drug will be produced in a laboratory based in a renowned University in New York. It will take at least 6 months to produce sufficient AVE-012 for a clinical trial which Alvin will participate in. Therefore, we need to raise the rest of the funds quickly so Alvin and others have a chance to win in their fight against cancer.
Thank you Father for touching the hearts of Your people for Alvin's sake. Father we pray that you continue touching more hearts as we claim victory for Your promise that whatever You begin You will finish. This we pray in the mighty name of Jesus Your Son, our Lord and Savior Amen!